SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
ConclusionThis study demonstrates that SARS-CoV-2 infects cardiomyocytesin vitro in an angiotensin-converting enzyme 2- and cathepsin-dependent manner. SARS-CoV-2 infection of cardiomyocytes is inhibited by the antiviral drug remdesivir.
Source: Cardiovascular Research - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Coronavirus | COVID-19 | Genetics | Heart | Pandemics | Respiratory Medicine | SARS | Stem Cell Therapy | Stem Cells | Study